Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette M Molinaro

Showing results (161-170 of 208) with videos related to

Pageof 21
Sort By:
Journal of Neurosurgery. Spine|April 25, 2020
The impact of obesity on perioperative complications in patients undergoing anterior lumbar interbody fusionMichael M Safaee, Alexander Tenorio, Joseph A Osorio, et al.
NPJ Digital Medicine|June 25, 2026
Spatially identifying regions of tumor recurrence in patients with suspected recurrent glioma using physiologic MRI and machine learningJacob Ellison, Nate Tran, Tracy L Luks, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomideGeno Guerra, George Wendt, Lucie McCoy, et al.
Neuro-Oncology|January 2, 2025
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomideGeno Guerra, George Wendt, Lucie McCoy, et al.
Neuro-Oncology Advances|July 25, 2025
Dissecting the biology of gliomagenesis: Evaluating the interaction between <i>IDH</i> tumor mutation and germline variantsMatthew L Kosel, Paul A Decker, Thomas M Kollmeyer, et al.
Neuro-Oncology Advances|December 23, 2020
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adultsJessica D Schulte, Robin A Buerki, Sarah Lapointe, et al.
Neuro-Oncology|April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomasYao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2026
A genomically-tailored multi-agent precision medicine clinical trial for adults with recurrent glioblastomaJiaying Chen, Nancy Ann Oberheim Bush, Jennifer A Grabowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2023
Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 TrialDaphne A Haas-Kogan, Mariam S Aboian, Jane E Minturn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent GlioblastomaLakshmi Nayak, Annette M Molinaro, Katherine Peters, et al.
Pageof 21

Showing results (161-170 of 208) with videos related to

Sort By:
Pageof 21
Journal of Neurosurgery. Spine|April 25, 2020
The impact of obesity on perioperative complications in patients undergoing anterior lumbar interbody fusionMichael M Safaee, Alexander Tenorio, Joseph A Osorio, et al.
NPJ Digital Medicine|June 25, 2026
Spatially identifying regions of tumor recurrence in patients with suspected recurrent glioma using physiologic MRI and machine learningJacob Ellison, Nate Tran, Tracy L Luks, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomideGeno Guerra, George Wendt, Lucie McCoy, et al.
Neuro-Oncology|January 2, 2025
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomideGeno Guerra, George Wendt, Lucie McCoy, et al.
Neuro-Oncology Advances|July 25, 2025
Dissecting the biology of gliomagenesis: Evaluating the interaction between <i>IDH</i> tumor mutation and germline variantsMatthew L Kosel, Paul A Decker, Thomas M Kollmeyer, et al.
Neuro-Oncology Advances|December 23, 2020
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adultsJessica D Schulte, Robin A Buerki, Sarah Lapointe, et al.
Neuro-Oncology|April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomasYao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2026
A genomically-tailored multi-agent precision medicine clinical trial for adults with recurrent glioblastomaJiaying Chen, Nancy Ann Oberheim Bush, Jennifer A Grabowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2023
Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 TrialDaphne A Haas-Kogan, Mariam S Aboian, Jane E Minturn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent GlioblastomaLakshmi Nayak, Annette M Molinaro, Katherine Peters, et al.
Pageof 21